Synlogic, Inc. and Mirna Therapeutics, Inc. Company Profile

05:49 EDT 26th June 2019 | BioPortfolio

News Articles [941 Associated News Articles listed on BioPortfolio]

Of Microbes And Men

This blog was written by Aoife Brennan, CEO of Synlogic Therapeutics, as part of the From The Trenches feature of LifeSciVC. I am the CEO of Synlogic, a synthetic biology company, where the focus of o...

Synlogic and Roche Partner for Immuno-Oncology Combination Therapy for Solid Tumors

Synlogic is partnering with Roche to develop Synlogic’s SYNB1891 with Roche’s checkpoint inhibitor Tecentriq (atezolizumab) in advanced solid tumors.

New Promega Maxwell® RSC miRNA Plasma and Serum Kit Introduced to the Market

The new Promega Maxwell® RSC miRNA plasma and serum kit, introduced to the market this week, provides quick, automated miRNA purification for oncology and translational researchers. Promega Corpor...

Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D

[Updated 10:42 a.m., see below.] Synlogic, a developer of so-called “living medicines” comprised of engineered bacteria, is teaming up with synthetic biology company Ginkgo Bioworks in an effort t...

Synlogic and Ginkgo Bioworks to develop biotic drugs

Synlogic has entered a platform collaboration with biotech company Ginkgo Bioworks to support its synthetic bionic medicines pipeline. The alliance...Read More... The post Synlogic and Ginkgo Bioworks...

Janssen’s Scott Plevy Joins Synlogic as Chief Scientific Officer

Synlogic (NASDAQ: SYBX) has appointed Scott Plevy to serve as chief scientific officer. A gastroenterologist, Plevy was most recently a vice president in gastroenterology disease at Janssen Research &...

Synlogic, Ginkgo Bioworks Launch Platform Collaboration to Develop “Synthetic Biotic” Treatments

Synlogic will use Ginkgo Bioworks’ cell programming platform to expand and further develop a pipeline of novel “living” medicines based on engineered probiotics, building upon a 1½-year-old col...

Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight

(Tokyo Medical and Dental University) Tokyo Medical and Dental University (TMDU) researchers used knockout mouse models created by gene editing to reveal that the miRNA miR-146b, like miR-146a, is inv...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [915 Associated PubMed Articles listed on BioPortfolio]

Nucleotide Modification Alters MicroRNA-Dependent Silencing of MicroRNA Switches.

mRNA therapeutics hold great promise for the treatment of human diseases. While incorporating naturally occurring modified nucleotides during synthesis has greatly increased their potency and safety, ...

A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is the most aggressive and prevalent subtype of breast cancer in women worldwide. Currently, chemotherapy remains the main modality for the treatment at an early s...

Delivery of therapeutic miRNA using polymer-based formulation.

MicroRNAs (miRNAs) are short non-coding RNAs that play important roles in many cellular processes such as development, proliferation, differentiation, and apoptosis. For this reason, miRNAs have been ...

The relationship between microRNAs and Rab family GTPases in human cancers.

microRNAs (miRNAs), as a group of noncoding RNAs, posttranscriptionally control gene expression by binding to 3'-untranslated region (3'-UTR). Ras-associated binding (Rab) proteins function as molecul...

Effect of Radiation on the Expression of CVD-related miRNAs, Inflammation and Endothelial Dysfunction of HUVECs.

Radiotherapy (RT) can lead to cardiovascular disease (CVD). Evidence suggests that radiation modulates miRNA levels. Our purpose was to assess the acute response to radiation-induced modulation of the...

Clinical Trials [256 Associated Clinical Trials listed on BioPortfolio]

microRNA Expression in Renal Cell Carcinoma

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look fo...

Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer

This study aims to analyze the expression of micro-RNA (miRNA) and long non-coding RNA (lncRNA) by next-generation sequencing in patients with high grade serous ovarian cancer (HGSOC) and ...

Plasma microRNA Profiling as First Line Screening Test for Lung Cancer Detection: a Prospective Study

In the present project we propose a large prospective study in heavy smokers volunteers based on plasma miRNA profiling to assess its efficacy as a first line screening test for lung cance...

miRNA Profile in Aneurysmal Subarachnoid Haemorrhage

The investigators aim to investigate and understand the circulating miRNA profiles after acute aneurysmal subarachnoid haemorrhage and underlying pathological significance.

Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients

The role of miRNAs in HIV disease is yet to be completely defined. Host miRNAs target certain HIV genes, thus can affect HIV replication and participate in viral control. miRNAs can also b...

Companies [1358 Associated Companies listed on BioPortfolio]

Synlogic, Inc. and Mirna Therapeutics, Inc.

Mirna Therapeutics Inc.

Mirna Therapeutics is a biotechnology company focused on the development and commercialization of microRNA (miRNA) therapeutics. The Company has a substantial body of pending i...

Mirna Therapeutics, Inc. and Horizon Discovery Ltd.

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company focused on the development and commercialization of miRNA therapeutics. The Company has a foundational intellectual pro...

Synlogic, Inc.

Synlogic is a private, biotechnology company, based in Cambridge, Massachusetts focused on delivering the potential of next generation synthetic biology to patients. Synlogic leve...

Mirna Therapeutics

Mirna Therapeutics, Inc. (Mirna) is a biotechnology company founded in late 2007 as a spin-off from Asuragen Inc. and is located in Austin, Texas. Mirna is focused on the developm...

More Information about "Synlogic, Inc. and Mirna Therapeutics, Inc." on BioPortfolio

We have published hundreds of Synlogic, Inc. and Mirna Therapeutics, Inc. news stories on BioPortfolio along with dozens of Synlogic, Inc. and Mirna Therapeutics, Inc. Clinical Trials and PubMed Articles about Synlogic, Inc. and Mirna Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synlogic, Inc. and Mirna Therapeutics, Inc. Companies in our database. You can also find out about relevant Synlogic, Inc. and Mirna Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record